
Suraksha Diagnostic Ltd Valuation Turns Attractive Amid Market Volatility
2026-11-20 08:00:59Suraksha Diagnostic Ltd has witnessed a notable shift in its valuation parameters, prompting an upgrade in its investment grade from Hold to Buy. With a current price of ₹330.00 and a micro-cap market classification, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have moved into more attractive territory compared to historical averages and peer benchmarks, signalling renewed investor interest despite recent price volatility.
Read More
Suraksha Diagnostic Ltd is Rated Buy by MarketsMOJO
2026-11-16 10:11:08Suraksha Diagnostic Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 04 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 November 2026, providing investors with the latest insights into its performance and outlook.
Read MoreSuraksha Diagnostic Gains 5.64%: 4 Key Factors Driving the Week’s Momentum
2026-11-07 10:02:39Key Events This Week 2 Nov: Stock opens strong at Rs.327.70 (+3.25%) amid bullish momentum shift 3 Nov: Technical momentum upgrade to bullish with price at Rs.327.05 (-0.20%) 4 Nov: MarketsMOJO upgrades rating to Buy; stock closes at Rs.333.10 (+1.85%) 5 Nov: Continued bullish momentum; stock closes at Rs.330.70 (-0.72%) 6 Nov: Week closes at Rs.335.30 (+1.39%) with positive technical signals <div class="stat-l...
Read More
Suraksha Diagnostic Ltd Upgraded to Buy on Strong Technical and Financial Performance
2026-11-05 08:45:26Suraksha Diagnostic Ltd, a micro-cap player in the healthcare services sector, has seen its investment rating upgraded from Hold to Buy following a comprehensive reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. The upgrade, effective from 4 November 2026, reflects a positive shift in the company’s market positioning and operational performance amid a challenging sector backdrop.
Read MoreSuraksha Diagnostic Gains 6.19%: Valuation Shift and Mixed Signals Shape the Week
2026-10-31 10:01:01Key Events This Week 26 Oct: Stock surged 4.37% to Rs.311.95 on strong volume 27 Oct: Minor correction of -0.51% to Rs.310.35 despite Sensex gains 29 Oct: Price jumped 2.75% to Rs.319.60 following rating downgrade news 30 Oct: Week ended with a slight dip of -0.69% to Rs.317.40 Week OpenRs.298.90 Week Close<div class=...
Read More
Suraksha Diagnostic Ltd Valuation Shifts Signal Changing Market Sentiment
2026-10-30 08:03:45Suraksha Diagnostic Ltd, a micro-cap player in the healthcare services sector, has seen its valuation parameters shift from very attractive to fair, reflecting a notable change in market perception. Despite a recent 2.75% rise in its share price to ₹319.60, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more tempered price attractiveness compared to historical and peer benchmarks.
Read More
Suraksha Diagnostic Ltd Technical Momentum Shifts Amid Mixed Market Returns
2026-10-13 08:08:01Suraksha Diagnostic Ltd, a micro-cap player in the Healthcare Services sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent decline in daily price, the stock’s year-to-date returns outperform the broader Sensex, signalling underlying strength amid short-term volatility.
Read More
Suraksha Diagnostic Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-10-12 08:03:58Suraksha Diagnostic Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish stance. This change is underpinned by positive signals from key indicators such as the MACD and moving averages, signalling renewed investor interest in the healthcare services micro-cap stock.
Read MoreSuraksha Diagnostic Ltd Falls 4.79%: 5 Key Factors Driving the Weekly Decline
2026-10-10 10:01:34Key Events This Week 5 Oct: Week opens at ₹331.05 with stable volume 6 Oct: Technical momentum shifts amid mixed market signals 8 Oct: Technical momentum upgrades to bullish despite price decline 9 Oct: Mojo Grade upgraded from Hold to Buy on improved fundamentals 9 Oct: Valuation metrics signal renewed price attractiveness Week OpenRs.331.05 ...
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
19-Nov-2026 | Source : BSEIntimation of availability of text transcript of Analysts/Investors meet-Earnings Call held on 13th November 2026 with respect to unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter ended 30th September 2026 and other business decisions.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13-Nov-2026 | Source : BSEIntimation of the audio recording of Analysts/Institutional Investors/Organisations meet- Earning Call for the quarter and half year ended 30 September 2026
Announcement under Regulation 30 (LODR)-Investor Presentation
12-Nov-2026 | Source : BSEInvestor Presentation for Quarter and Half Year ended 30 September 2026 Q2 FY 2026-27
Corporate Actions
No Upcoming Board Meetings
Suraksha Diagnostic Ltd has declared 25% dividend, ex-date: 15 Sep 26
No Splits history available
No Bonus history available
No Rights history available